Subash Srinivasan

Subash Srinivasan has extensive experience in the pharmaceutical industry, starting with their role as a Research Physician at UCB Pharma from 2007 to 2010. Subash then joined Bristol-Myers Squibb, where they held various positions, including Senior Medical Advisor, Medical Manager, and Immuno-Oncology Medical Lead from 2010 to 2017. Following that, Subash worked as the UK Medical Director at Chugai Pharma UK from 2017 to 2021, and as the Senior Medical Director for the UK, Ireland, and Nordics at Intercept Pharmaceuticals from 2021 to 2022. Subash is currently serving as the Senior Medical Director for the UK, Ireland, and Nordics at ADVANZ PHARMA, starting in 2022.

Subash Srinivasan has a diverse education history in the field of pharmaceutical medicine. Subash first obtained a Bachelor of Science (BSc) in Pharmacology from King's College London in 2001. Following this, they pursued a Bachelor of Medicine, Bachelor of Surgery (MBBS) degree from St George's, University of London, completing it in 2003. In 2007, Subash went on to earn a Master of Science (MSc) in Experimental Therapeutics from the University of Oxford. Subash then focused on pharmaceutical medicine, obtaining a Diploma of Pharmaceutical Medicine from the Faculty of Pharmaceutical Medicine in 2012. Subash further advanced their knowledge and skills in pharmaceutical medicine by completing the Certificate of Completion of Training (CCT) from the same faculty in the period between 2008 and 2013. Their most recent educational milestone was achieved in 2019 when they became a Fellow of Faculty of Pharmaceutical Medicine from the same institution.